Patents by Inventor Yufu Li

Yufu Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11455261
    Abstract: An embodiment of a semiconductor package apparatus may include technology to identify a partial set of populated memory channels from a full set of populated memory channels of a multi-channel memory system, and complete a first boot of an operating system with only the identified partial set of memory channels of the multi-channel memory system. Other embodiments are disclosed and claimed.
    Type: Grant
    Filed: September 29, 2017
    Date of Patent: September 27, 2022
    Assignee: Intel Corporation
    Inventors: Kevin Yufu Li, Donggui Yin, Zijian You, Shihui Li, Dujian Wu
  • Publication number: 20220288285
    Abstract: Disclosed are a cationic nanodrug, a preparation method therefor, and a drug-loaded implantable medical device, wherein the cationic nanodrug comprises a vector and a drug loaded on the vector, and the vector comprises one or more of a cationic amphipathic compound and a cationic modifier; the cationic amphipathic compound is a cationic amphipathic compound containing amino and/or acyl; and the cationic modifier is a cationic modifier containing amino and/or acyl. The cationic nanodrug greatly improves the uptake of a drug by cells and has a good slow-release effect.
    Type: Application
    Filed: September 1, 2020
    Publication date: September 15, 2022
    Inventors: Meng LI, Yufu WANG, Junfei LI
  • Patent number: 11413192
    Abstract: The present invention is directed to a flowable hemostatic paste comprising a crosslinked carboxymethyl cellulose and at least one non-toxic dispersant. More specifically the present invention relates to a hemostatic paste containing citric acid cross-linked CMC, which is suspended or dispersed as a powder in a mixture of a first non-toxic glycerol-containing hygroscopic dispersant and a second non-toxic alcohol functionalized dispersant comprising propylene glycol or 1,3-butanediol.
    Type: Grant
    Filed: June 25, 2020
    Date of Patent: August 16, 2022
    Assignees: Guangzhou Bioseal Co., Ltd., Johnson & Johnson China Ltd., Ethicon Inc.
    Inventors: Dengmin Feng, Ling Teng, Yanhui Zhang, Guojun Ni, Yufu Li, Xiang Wan
  • Patent number: 11413335
    Abstract: The present invention is directed to hemostatic compositions comprising at least partially integrated agglomerated ORC fibers, fibrinogen, and thrombin and methods of forming a powdered hemostatic composition, comprising the steps of: forming a suspension of a mixture comprising particles of fibrinogen, thrombin, ORC fibers in a non-aqueous low boiling solvent, agitating and shearing said suspension in a high shear mixing reactor, adding water to allow particles to agglomerate, allowing the non-aqueous solvent to evaporate, drying and sieving the composition; and thus forming the powdered hemostatic composition.
    Type: Grant
    Filed: February 13, 2018
    Date of Patent: August 16, 2022
    Assignees: Guangzhou Bioseal Biotech Co. Ltd, Ethicon, Inc.
    Inventors: Shuang Chen, Yufu Li, Aibin Yu, Jianping Yu
  • Patent number: 11400180
    Abstract: The present invention relates generally to agents and devices for promoting hemostasis and tissue sealing and, more particularly, to hemostatic pads comprising bioabsorbable scaffolds that can deliver lyophilized hemostasis promoting proteins, such as fibrinogen and thrombin, to a wound site or injured organ or tissue.
    Type: Grant
    Filed: February 5, 2020
    Date of Patent: August 2, 2022
    Assignee: Ethicon, Inc.
    Inventors: Randolph W. Hubbell, James Eckhardt, Jerome Riebman, Yufu Li, Michael Elser
  • Publication number: 20220202619
    Abstract: The present invention is directed to a flowable hemostatic paste comprising a crosslinked carboxymethyl cellulose and at least one non-toxic dispersant. More specifically the present invention relates to a hemostatic paste containing citric acid cross-linked CMC, which is suspended or dispersed as a powder in a mixture of a first non-toxic glycerol-containing hygroscopic dispersant and a second non-toxic alcohol functionalized dispersant comprising propylene glycol or 1,3-butanediol.
    Type: Application
    Filed: March 21, 2022
    Publication date: June 30, 2022
    Inventors: Dengmin Feng, Ling Teng, Yanhui Zhang, Guojun Ni, Yufu Li, Xiang Wan
  • Publication number: 20220111020
    Abstract: The present invention is directed to hemostatic compositions comprising at least partially integrated agglomerated ORC fibers, fibrinogen, and thrombin and methods of forming a powdered hemostatic composition, comprising the steps of: forming a suspension of a mixture comprising particles of fibrinogen, thrombin, ORC fibers in a non-aqueous low boiling solvent, agitating and shearing said suspension in a high shear mixing reactor, adding water to allow particles to agglomerate, allowing the non-aqueous solvent to evaporate, drying and sieving the composition; and thus forming the powdered hemostatic composition.
    Type: Application
    Filed: December 23, 2021
    Publication date: April 14, 2022
    Inventors: Shuang Chen, Yufu Li, Aibin Yu, Jianping Yu
  • Publication number: 20220096708
    Abstract: The present invention is directed to hemostatic compositions comprising at least partially integrated agglomerated ORC fibers, fibrinogen, and thrombin and methods of forming a powdered hemostatic composition, comprising the steps of: forming a suspension of a mixture comprising particles of fibrinogen, thrombin, ORC fibers in a non-aqueous low boiling solvent; spraying the suspension through a nozzle onto a substrate, allowing the non-aqueous solvent to evaporate; separating from the substrate and sieving the composition.
    Type: Application
    Filed: December 13, 2021
    Publication date: March 31, 2022
    Inventors: Shuang Chen, Yufu Li, Dengmin Feng, Xiang Wan
  • Patent number: 11229720
    Abstract: The present invention is directed to hemostatic compositions comprising at least partially integrated agglomerated oxidized regenerated cellulose (ORC) fibers, fibrinogen, and thrombin and methods of forming a powdered hemostatic composition, comprising the steps of: forming a suspension of a mixture comprising particles of fibrinogen, thrombin, ORC fibers in a non-aqueous low boiling solvent; spraying the suspension through a nozzle onto a substrate, allowing the non-aqueous solvent to evaporate; separating from the substrate and sieving the composition.
    Type: Grant
    Filed: September 7, 2016
    Date of Patent: January 25, 2022
    Assignee: Guangzhou Bioseal Biotech Co., Ltd.
    Inventors: Shuang Chen, Yufu Li, Dengmin Feng, Xiang Wan
  • Publication number: 20210397530
    Abstract: Methods, apparatus, systems, and articles of manufacture are disclosed to transmit central processing unit (CPU) performance information to an operating system (OS). An apparatus comprising interface circuitry, and processor circuitry to perform at least one of the first operations, the second operations or the third operations to: a CPU detector circuitry to determine a connection status between a first CPU and a second CPU, an encoder circuitry to generate a first CPU identifier for the first CPU port and a second CPU identifier for the second CPU port, a topology identifier circuitry to identify a topology based on the connection status and the CPU identifiers, a transaction performance level (TPL) calculator circuitry to calculate a TPL based on at least one of the connection status, the CPU identifiers, and a topology identifier circuitry, and a TPL transmitter circuitry to transmit the TPL to an OS.
    Type: Application
    Filed: June 25, 2021
    Publication date: December 23, 2021
    Inventors: Lei Zhu, Kevin Yufu Li, Shijie Liu, Tao Xu
  • Patent number: 10970206
    Abstract: Methods, apparatus, and system to compress a data file to form a compressed data file. The data file may be used to configure control of hardware, such as peripheral hardware. The compressed data file may be stored locally or transmitted to another computer device. The compressed data file may be stored in a flash memory. The compressed data file may require less space in flash memory components, relative to flash memory suitable to hold the (original, pre-compressed) data file. Compression and/or decompression may be performed by, for example, a flash memory controller. The compressed data file may be decompressed dynamically, on an as-needed basis, to provide code for execution by a processor and/or to configure a computer device to use hardware or other components. Other software and hardware components do not need to be aware that the data file is compressed in the flash memory.
    Type: Grant
    Filed: March 16, 2017
    Date of Patent: April 6, 2021
    Assignee: Intel Corporation
    Inventors: Fumin Lu, Yufu Li, Peng Wang, Xiaoguo Liang, Ye Li
  • Patent number: 10918388
    Abstract: The present invention relates to surgical instruments and methods for enhancing properties of tissue repaired or joined by surgical staples and, more particularly to surgical instruments and methods designed to enhance the properties of repaired or adjoined tissue at a target surgical site, especially when sealing an anastomosis between adjacent intestinal sections so as to improve tissue viability, prevent tissue infection, and to prevent leakage.
    Type: Grant
    Filed: August 23, 2018
    Date of Patent: February 16, 2021
    Assignee: Ethicon, Inc.
    Inventors: Nir I. Nativ, Yufu Li, Michael Logue, Glenn Cook, Gwan-Ywan Lai
  • Publication number: 20200364162
    Abstract: An embodiment of a semiconductor package apparatus may include technology to identify a partial set of populated memory channels from a full set of populated memory channels of a multi-channel memory system, and complete a first boot of an operating system with only the identified partial set of memory channels of the multi-channel memory system.
    Type: Application
    Filed: September 29, 2017
    Publication date: November 19, 2020
    Applicant: Intel Corporation
    Inventors: Kevin Yufu Li, Donggui Yin, Zijian You, Shihui Li, Dujian Wu
  • Publication number: 20200323690
    Abstract: The present invention is directed to a flowable hemostatic paste comprising a crosslinked carboxymethyl cellulose and at least one non-toxic dispersant. More specifically the present invention relates to a hemostatic paste containing citric acid cross-linked CMC, which is suspended or dispersed as a powder in a mixture of a first non-toxic glycerol-containing hygroscopic dispersant and a second non-toxic alcohol functionalized dispersant comprising propylene glycol or 1,3-butanediol.
    Type: Application
    Filed: June 25, 2020
    Publication date: October 15, 2020
    Inventors: Dengmin Feng, Ling Teng, Yanhui Zhang, Guojun Ni, Yufu Li, Xiang Wan
  • Patent number: 10765774
    Abstract: The present invention relates generally to agents and devices for promoting hemostasis and tissue sealing and, more particularly, to hemostatic pads comprising bioabsorbable scaffolds that can deliver lyophilized hemostasis promoting proteins, such as fibrinogen and thrombin, to a wound site or injured organ or tissue.
    Type: Grant
    Filed: July 9, 2013
    Date of Patent: September 8, 2020
    Assignee: Ethicon, Inc.
    Inventors: Randolph W. Hubbell, James Eckhardt, Jerome Riebman, Yufu Li, Michael Elser
  • Patent number: 10736786
    Abstract: The present invention is directed to a flowable hemostatic paste comprising a crosslinked carboxymethyl cellulose and at least one non-toxic dispersant. More specifically the present invention relates to a hemostatic paste containing citric acid cross-linked CMC, which is suspended or dispersed as a powder in a mixture of a first non-toxic glycerol-containing hygroscopic dispersant and a second non-toxic alcohol functionalized dispersant comprising propylene glycol or 1,3-butanediol.
    Type: Grant
    Filed: August 6, 2018
    Date of Patent: August 11, 2020
    Assignees: Guangzhou Bioseal Biotech Co., Ltd., Johnson & Johnson China Ltd., Ethicon, Inc.
    Inventors: Dengmin Feng, Ling Teng, Yanhui Zhang, Guojun Ni, Yufu Li, Xiang Wan
  • Publication number: 20200171197
    Abstract: The present invention relates generally to agents and devices for promoting hemostasis and tissue sealing and, more particularly, to hemostatic pads comprising bioabsorbable scaffolds that can deliver lyophilized hemostasis promoting proteins, such as fibrinogen and thrombin, to a wound site or injured organ or tissue.
    Type: Application
    Filed: February 5, 2020
    Publication date: June 4, 2020
    Inventors: Randolph W. Hubbell, James Eckhardt, Jerome Riebman, Yufu Li, Michael Elser
  • Patent number: 10646623
    Abstract: An implantable medical device, which comprises a device substrate, a coating on the substrate which includes a drug, and a protective layer which overlies the coating. The protective layer comprises a polymer selected from the group consisting of polylactic acid, polyglycolic acid and a lactic acid/glycolic acid copolymer having a weight average molecular weight of not more than 40,000.
    Type: Grant
    Filed: December 1, 2017
    Date of Patent: May 12, 2020
    Assignee: DePuy International Limited
    Inventors: Yufu Li, Deborah Schachter, Raymond S. Shissias, Sandra Wechsler
  • Publication number: 20200022843
    Abstract: The present invention is directed to a flowable hemostatic paste comprising a crosslinked carboxymethyl cellulose and at least one non-toxic dispersant. More specifically the present invention relates to a hemostatic paste containing citric acid cross-linked CMC, which is suspended or dispersed as a powder in a mixture of a first non-toxic glycerol-containing hygroscopic dispersant and a second non-toxic alcohol functionalized dispersant comprising propylene glycol or 1,3-butanediol.
    Type: Application
    Filed: August 6, 2018
    Publication date: January 23, 2020
    Inventors: Dengmin Feng, Ling Teng, Yanhui Zhang, Guojun Ni, Yufu Li, Xiang Wan
  • Publication number: 20190347194
    Abstract: Methods, apparatus, and system to compress a data file to form a compressed data file. The data file may be used to configure control of hardware, such as peripheral hardware. The compressed data file may be stored locally or transmitted to another computer device. The compressed data file may be stored in a flash memory. The compressed data file may require less space in flash memory components, relative to flash memory suitable to hold the (original, pre-compressed) data file. Compression and/or decompression may be performed by, for example, a flash memory controller. The compressed data file may be decompressed dynamically, on an as-needed basis, to provide code for execution by a processor and/or to configure a computer device to use hardware or other components. Other software and hardware components do not need to be aware that the data file is compressed in the flash memory.
    Type: Application
    Filed: March 16, 2017
    Publication date: November 14, 2019
    Inventors: Fumin LU, Yufu LI, Peng WANG, Xiaoguo LIANG, Ye LI